A study on the potential of Polyscias fruticosa (L.) Harms root extract to reduce blood glucose levels

Abstract

Polyscias fruticosa (L.) Harms is known as a medicinal herb used in traditional medicine to prevent cough and reduce inflammatory. This study examines the potential of Polyscias fruticosa (L.) Harms root extract to reduce blood glucose levels in Swiss mice. The study’s experiments show that the aqueous extract of P. fruticosa caused no death in the mice (LD50 > 5000 mg/kg). The results of sub-acute toxicity tests shows that all the treated mice at the doses of 200 mg/kg survived throughout the 14 days of treatment. The test of blood glucose reducion potential shows that the root extract with the concentration of 200 mg/kg had no statistically significant difference compared with the glucose level of normal mice, and the weight of tested mice had no difference throughout treatment progress (p < 0.05). Staining of pancreatic tissue of mice by hematoxylin - eosin showed that the high ethanol can restore pancreatic islet cells.
Keywords
Polyscias fruticosa (L.) Harms preventing cough anti-inflammatory diabetes

References

1.
American Diabetes Association (2006). Diagnosis and classification of diabetes mellitus. Diabetes Care, 29, S43-S48.
2.
P. R. Rehani et al. (2019). Safety and mode of action of diabetes medications in comparison with 5-aminolevulinic acid (5-ALA). J. Diabetes Res., 2019, 1-10.
3.
T. T. H. Hanh et al. (2016). á-Amylase and á-glucosidase inhibitory saponins from Polyscias fruticosa leaves. J. Chem., 2016, 1-5.
4.
B. L. Furman (2021). Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr. Protoc., 1(4), 1-5.
5.
F. Rivera-Ramírez et al. (2011). Antiobesity and hypoglycaemic effects of aqueous extract of Ibervillea sonorae in mice fed a high-fat diet with fructose. J. Biomed. Biotechnol., 2011, 1-6.
6.
C. J. Ugwah-Oguejiofor et al. (2019). Acute and sub-acute toxicity of aqueous extract of aerial parts of Caralluma dalzielii NE Brown in mice and rats. Heliyon, 5(1), 1-20.
7.
R. D. Cardiff et al. (2014). Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb. Protoc., 2014(6), 655-658.
8.
A. Ramachandran et al. (2012). Trends in prevalence of diabetes in Asian countries. World J. Diabetes, 3(6), 110-117.
9.
O. M. Akinlade et al. (2021). Streptozotocin-induced type 1 and 2 diabetes in rodents: a model for studying diabetic cardiac autonomic neuropathy. Afr. Health Sci., 21(2), 719-727.
10.
S. O. Adewole and J. A. O. Ojewole. (2007). Insulin-induced immunohistochemical and morphological changes in pancreatic b-cells of streptozotocin-treated diabetic rats. Methods Find. Exp. Clin. Pharmacol., 29(7), 447-456.